WORX Quote, Financials, Valuation and Earnings

CVS Health has a net margin of -66.13% compared to SCWorx's net margin of 1.88%. SCWorx's return on equity of -32.77% beat CVS Health's return on equity of 7%.

SCWorx has a consensus price target of --, signalling downside risk potential of --. On the other hand CVS Health has an analysts' consensus of $79.29 which suggests that it could grow by 30.34%. Given that CVS Health has higher upside potential than SCWorx, analysts believe CVS Health is more attractive than SCWorx.

SCWorx has a beta of 2.355, which suggesting that the stock is 135.489% more volatile than S&P 500. In comparison CVS Health has a beta of 0.598, suggesting its less volatile than the S&P 500 by 40.158%.

SCWorx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CVS Health offers a yield of 4.37% to investors and pays a quarterly dividend of $0.67 per share. SCWorx pays -- of its earnings as a dividend. CVS Health pays out 73.1% of its earnings as a dividend. CVS Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

SCWorx quarterly revenues are $720.3K, which are smaller than CVS Health quarterly revenues of $94.6B. SCWorx's net income of -$476.3K is lower than CVS Health's net income of $1.8B. Notably, SCWorx's price-to-earnings ratio is -- while CVS Health's PE ratio is 14.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx is 0.23x versus 0.20x for CVS Health. Usually stocks with elevated PS ratios are considered overvalued.

First Physicians Capital Group has a net margin of -66.13% compared to SCWorx's net margin of --. SCWorx's return on equity of -32.77% beat First Physicians Capital Group's return on equity of --.

SCWorx has a consensus price target of --, signalling downside risk potential of --. On the other hand First Physicians Capital Group has an analysts' consensus of -- which suggests that it could fall by --. Given that SCWorx has higher upside potential than First Physicians Capital Group, analysts believe SCWorx is more attractive than First Physicians Capital Group.

SCWorx has a beta of 2.355, which suggesting that the stock is 135.489% more volatile than S&P 500. In comparison First Physicians Capital Group has a beta of -12.606, suggesting its less volatile than the S&P 500 by 1360.624%.

SCWorx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. First Physicians Capital Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SCWorx pays -- of its earnings as a dividend. First Physicians Capital Group pays out -- of its earnings as a dividend.

SCWorx quarterly revenues are $720.3K, which are larger than First Physicians Capital Group quarterly revenues of --. SCWorx's net income of -$476.3K is higher than First Physicians Capital Group's net income of --. Notably, SCWorx's price-to-earnings ratio is -- while First Physicians Capital Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx is 0.23x versus 1.40x for First Physicians Capital Group. Usually stocks with elevated PS ratios are considered overvalued.

IQVIA Holdings has a net margin of -66.13% compared to SCWorx's net margin of 6.5%. SCWorx's return on equity of -32.77% beat IQVIA Holdings's return on equity of 20.79%.

SCWorx has a consensus price target of --, signalling downside risk potential of --. On the other hand IQVIA Holdings has an analysts' consensus of $190.62 which suggests that it could grow by 39.14%. Given that IQVIA Holdings has higher upside potential than SCWorx, analysts believe IQVIA Holdings is more attractive than SCWorx.

SCWorx has a beta of 2.355, which suggesting that the stock is 135.489% more volatile than S&P 500. In comparison IQVIA Holdings has a beta of 1.344, suggesting its more volatile than the S&P 500 by 34.416%.

SCWorx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IQVIA Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SCWorx pays -- of its earnings as a dividend. IQVIA Holdings pays out -- of its earnings as a dividend.

SCWorx quarterly revenues are $720.3K, which are smaller than IQVIA Holdings quarterly revenues of $3.8B. SCWorx's net income of -$476.3K is lower than IQVIA Holdings's net income of $249M. Notably, SCWorx's price-to-earnings ratio is -- while IQVIA Holdings's PE ratio is 18.66x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx is 0.23x versus 1.61x for IQVIA Holdings. Usually stocks with elevated PS ratios are considered overvalued.

UNIVEC has a net margin of -66.13% compared to SCWorx's net margin of --. SCWorx's return on equity of -32.77% beat UNIVEC's return on equity of --.

SCWorx has a consensus price target of --, signalling downside risk potential of --. On the other hand UNIVEC has an analysts' consensus of -- which suggests that it could fall by --. Given that SCWorx has higher upside potential than UNIVEC, analysts believe SCWorx is more attractive than UNIVEC.

SCWorx has a beta of 2.355, which suggesting that the stock is 135.489% more volatile than S&P 500. In comparison UNIVEC has a beta of 0.070, suggesting its less volatile than the S&P 500 by 93.018%.

SCWorx has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UNIVEC offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. SCWorx pays -- of its earnings as a dividend. UNIVEC pays out -- of its earnings as a dividend.

SCWorx quarterly revenues are $720.3K, which are larger than UNIVEC quarterly revenues of --. SCWorx's net income of -$476.3K is higher than UNIVEC's net income of --. Notably, SCWorx's price-to-earnings ratio is -- while UNIVEC's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for SCWorx is 0.23x versus -- for UNIVEC. Usually stocks with elevated PS ratios are considered overvalued.